Handbook for Investors Jun 08, 2023 Handbook for Investors The handbook provides information on the most important aspects of Switzerland as a modern and innovative business and technology location. It co...
Tecnologie e settori svizzeri Settori chiave Le associazioni e le organizzazioni di settore, nel loro ruolo di partner della rete nazionale di Switzerland Global Enterprise (S-GE), assicuran...
Report Jul 21, 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
News Jun 21, 2021 Pharmaplan opens a branch in Visp In response to the investment surge in the pharmaceutical industry, the TTP Group is opening a new Pharmaplan office on the Visp biotechnology si...
Success stories Sep 15, 2017 The Luye Life Sciences Group establishes its European headquarters in Basel Luye Pharma AG With its own product pipeline and several subsidiaries abroad, Luye Pharma is a pioneer in the Chinese pharmaceutical industry. The new European ...
News May 10, 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...
Technologien + Branchen Branchen Branchenverbände und Sektororganisationen stellen als Partner im nationalen Netzwerk von Switzerland Global Enterprise (S-GE) sicher, dass die In...
News Apr 27, 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...
Aktuell Mar 08, 2023 Bachem bekommt Auftrag im Volumen von über 500 Millionen Franken Bachem hat einen langfristigen Kooperationsvertrag über die Entwicklung und Herstellung von Peptiden akquiriert. Er umfasst ein bindendes Auftrag...
News Jan 26, 2021 Opterion Health AG moving to Muttenz Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from the local life sciences ecos...
Actualités Nov 01, 2023 L’usine de Bacthera à Viège entend révolutionner les thérapies microbiomiques A Viège, le centre d’excellence MC4a de Bacthera se prépare à fabriquer des thérapies microbiomiques transformatrices, notamment le SER-109 de Se...
News Aug 03, 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Fact Sheet May 04, 2022 Advanced Manufacturing in Switzerland As a production location, Switzerland offers companies optimal conditions to optimize their manufacturing processes through increased efficiency ...
Fact Sheet Jun 09, 2022 Switzerland - a hub for personalized health The close collaboration between science and industry is unique in Switzerland: Companies in the life sciences sector benefit from fast technology...
Actualités Oct 25, 2023 Mecaplast Swiss, 50 ans d’innovation dans le canton de Fribourg Riche d’une histoire de cinq décennies, Mecaplast Swiss s’est imposée comme un leader de l’industrie de l’injection plastique, notamment grâce à ...
News Jul 18, 2023 AI uncovers drug to treat rare pediatric disease The University of Zurich has identified a way to help children suffering from cystinosis in partnership with Insilico Medicine and the company’s ...
Actualités Oct 23, 2023 Valsynthèse, 40 ans d’innovation en Valais De la dynamite aux produits pharmaceutiques, Valsynthèse, l’unité « chimie fine » de la Société Suisse des Explosifs, fête quatre décennies de so...